Cantex Pharmaceuticals Competitors and Similar CompaniesClear all
Exelixis's competitors and similar companies include Nykode Therapeutics.
 Nykode Therapeutics Nykode Therapeutics (formerly known as Vaccibody) is a biopharmaceutical company dedicated to the discovery and development of immunotherapies. | ||
Founding Date | Founding Date 1994 | Founding Date 2007 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Alameda, US HQ | Locations Oslo, NO HQ |
Employees | Employees 1,14712% decrease | Employees 135 |
Valuation ($) | Valuation ($) 8.2 b | Valuation ($) 144.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $83.7m (FY, 2025) | Cost of goods $1.3m (FY, 2025) |
Gross profit | Gross profit $2.2b (FY, 2025) | Gross profit ($801k) (FY, 2025) |
Net income | Net income $782.6m (FY, 2025) | Net income ($12.2m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Nykode Therapeutics
HQ
Oslo, NO
Employees
135
Nykode Therapeutics (formerly known as Vaccibody) is a biopharmaceutical company dedicated to the discovery and development of immunotherapies.
View company